US OptionsDetailed Quotes

CTSO250117C5000

Watchlist

0.00
0.000.00%

15min DelayClose Jan 10 09:30 ET

0.00High0.00Low

Cytosorbents Stock Discussion

Jaguar8

Jan 6 06:06

NEWS

$Cytosorbents (CTSO.US)$
CytoSorbents Expands Global Footprint with Opening of New Regional Sales Subsidiary in Dubai
Monday, 6th January at 7:00 am
PRINCETON, N.J., Jan. 06, 2025 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today announced the opening of a new regional sales subsidiary in Dubai, United Arab Emirates (UAE). The new subsidiary provid...

JesseGio1989

Jan 3 13:36

$Cytosorbents (CTSO.US)$ back up to 1.50! Get in before the volume hits us

Jaguar8

Nov 11, 2024 06:30

NEWS

$Cytosorbents (CTSO.US)$
CytoSorbents And Converge Biotech Announce Strategic Partnership to Expand Sepsis and Critical Care Treatment with CytoSorb in India
CytoSorbents (NASDAQ: CTSO) and Converge Biotech have announced a strategic partnership to expand their market reach in India's sepsis and critical care markets. CytoSorbents' flagship product, CytoSorb, a blood purification technology that reduces cytokine storm and inflammatory toxins, will be distributed through Converge Biotech's ext...

Stock_Drift

Oct 1, 2024 04:35

10/1/24 Pre_Market Ticks, 5:33am est.

$Kaixin Holdings (KXIN.US)$ $Cytosorbents (CTSO.US)$ $MicroCloud Hologram (HOLO.US)$ $Bionomics (BNOX.US)$ $Tuniu (TOUR.US)$ $ZK International (ZKIN.US)$ $SHINECO (SISI.US)$ $XChange TEC (XHG.US)$ $SITE Centers (SITC.US)$ $AgEagle Aerial Systems (UAVS.US)$

Mcsnacks H Tupack

Jul 29, 2024 14:38

Broke resistance

$Cytosorbents (CTSO.US)$ It can run from here.

Jaguar8

May 2, 2024 06:08

$Cytosorbents (CTSO.US)$
NEWS
CytoSorbents May 6, 2024 Virtual KOL and Analyst-Investor Day: STAR-T Pivotal Trial Topline Results & Real World Experience with Antithrombotic Drug Removal in Europe

Moomoo AI

Dec 28, 2023 13:41

Despite promising growth forecasts, investor sentiment appears reserved, as revealed in the company's P/S ratio. Additionally, the recent stock price surge didn't significantly affect the P/S ratio, implying tempered revenue expectations. The high-growth yet low P/S ratio raises caution in market.